Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Immunoglobulins Market Grown from 2024 to 2025?

The market for immunoglobulins has experienced substantial growth in the past few years. Its value is projected to rise from $18.85 billion in 2024 to $20.53 billion in 2025, representing a compound annual growth rate (CAGR) of 8.9%. The growth observed in the historical period can be attributed to a higher prevalence of immunodeficiency disorders, an expanding elderly population, an increasing acceptance of immunoglobulins in hospital settings, generous government reimbursement schemes, and a growing incidence of chronic and autoimmune diseases.

What Growth Rate Is Anticipated for the Immunoglobulins Market in the Coming Years?

The market for immunoglobulins is set to see impressive expansion in the coming years, with predictions indicating growth up to $31.59 billion by 2029 and a compound annual growth rate (CAGR) of 11.4%. This estimated growth in the forecasted period is attributed to a rise in funds devoted to the development of cutting-edge technologies, heightened understanding and use of immunodeficiency therapies, an increased preference for these therapies among medical professionals, and flourishing emerging markets. The applications’ broadening scope in areas such as sports and fitness will also fuel this growth. The forecast period will also see the rising trends of smart wearable compression devices, personalised compression therapy solutions, the incorporation of compression therapy into wound care management, focus on patient comfort in compression therapy, and a strategic partnership between manufacturers and healthcare providers to better patient outcomes.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5284&type=smp

Who Are the Leading Companies in the Immunoglobulins Market?

Major companies operating in the immunoglobulins market include Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited

What Are the Key Drivers of the Immunoglobulins Market?

The growth of the immunoglobulins market is driven by the rising elderly populace. Elderly individuals are at a high risk for infectious and autoimmune diseases, thus necessitating the use of immunoglobulin tests to ascertain the body’s capacity to produce disease-fighting antibodies against bacteria, viruses, and allergies. A report published by the World Health Organization (WHO), a Switzerland-based international public health agency, in October 2022 states that by 2030, one out of every six individuals globally will be at least 60 years old. By 2050, the number of those aged 60 or above worldwide is projected to reach 2.1 billion. Consequently, the growing elderly population is anticipated to spur demand for the immunoglobulins market in the forecast period.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=5284&type=smp

What Are the Key Market Segments in the Immunoglobulins Industry?

The immunoglobulins market covered in this report is segmented –

1) By Product: IGG, IGA, IGM, IGE, IGD.

2) By Mode Of Delivery: Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery

3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications

Subsegments:

1) By IGG (Immunoglobulin G): IVIG (Intravenous Immunoglobulin), SCIG (Subcutaneous Immunoglobulin)

2) By IGA (Immunoglobulin A): Monoclonal IGA, Polyvalent IGA

3) By IGM (Immunoglobulin M): Monoclonal IGM, Polyvalent IGM

4) By IGE (Immunoglobulin E): Allergen-Specific IGE, Monoclonal IGE

5) By IGD (Immunoglobulin D): Research-Use IGD, Monoclonal IGD

What Are the Latest Trends in the Immunoglobulins Market?

Key players in the immunoglobulins market, are focusing on the creation of novel products, like intravenous immunoglobulins, with an intention to cater to a bigger consumer base, boost sales, and increase their revenue. In one such development, GC Biopharma, a biotech firm based in South Korea, introduced ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid to the U.S. market in September 2024. It is designed to treat primary humoral immunodeficiency (PI) in adults who are 17 years or older. It can now be accessed by patients from specialty pharmacies. This move is critical given the U.S. has the biggest immunoglobulin market worldwide, with an estimated worth of around $11.6 billion. With a sales target of $50 million for ALYGLO in the initial year, GC Biopharma’s objective is to raise this number to $300 million by 2028. This aggressive growth plan includes tie-ups with leading U.S. pharmacy benefit managers and specialty pharmacies, which are essential for the efficient distribution of immunoglobulin products.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

What Are the Key Regional Markets in the Immunoglobulins Industry?

North America was the largest region in the immunoglobulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5284

This Report Delivers Insight On:

1. How big is the immunoglobulins market, and how is it changing globally?

2. Who are the major companies in the immunoglobulins market, and how are they performing?

3. What are the key opportunities and risks in the immunoglobulins market right now?

4. Which products or customer segments are growing the most in the immunoglobulins market?

5. What factors are helping or slowing down the growth of the immunoglobulins market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model